✦ LIBER ✦

Combining Yttrium 90–Labeled Ibritumomab Tiuxetan with High-Dose Chemotherapy and Stem Cell Support in Patients with Relapsed Non-Hodgkin's Lymphoma

✍ Scribed by Winter, Jane N.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Ongoing Trials with Yttrium 90–Labeled I

✍ Micallef, Ivana N.M. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 366 KB

Yttrium-90–ibritumomab tiuxetan (Zevalin

✍ Avichai Shimoni; S. Tzila Zwas; Yakov Oksman; Izhar Hardan; Noga Shem-Tov; Ronit 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 186 KB

Weight-Based Dosing of Yttrium 90 Ibritu

✍ Wiseman, Gregory A.; Conti, Peter S.; Vo, Katie; Schilder, Russell J.; Gordon, L 📂 Article 📅 2007 🏛 CIG Media Group, LP. 🌐 English ⚖ 106 KB

Safety and Efficacy of Yttrium-90 Ibritu

✍ Emmanouilides, Christos; Witzig, Thomas E.; Wiseman, Gregory A.; Gordon, Leo I.; 📂 Article 📅 2007 🏛 Mary Ann Liebert 🌐 English ⚖ 149 KB

Factors Associated with Toxicity and Res

✍ Borghaei, Hossein; Wallace, Stephen G.; Schilder, Russell J. 📂 Article 📅 2004 🏛 CIG Media Group, LP. 🌐 English ⚖ 113 KB

Treatment with yttrium 90 ibritumomab ti

✍ Emmanouilides, Christos; Witzig, Thomas E.; Gordon, Leo I.; Vo, Katie; Wiseman, 📂 Article 📅 2006 🏛 Informa plc 🌐 English ⚖ 352 KB